ETF Managers Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,468
Closed -$534K 698
2021
Q1
$534K Buy
1,468
+196
+15% +$63K 0.01% 417
2020
Q4
$399K Sell
1,272
-1,459
-53% -$448K 0.01% 444
2020
Q3
$709K Buy
2,731
+5
+0.2% +$1.34K 0.02% 251
2020
Q2
$707K Sell
2,726
-1,203
-31% -$321K 0.03% 226
2020
Q1
$906K Buy
3,929
+3,069
+357% +$836K 0.04% 162
2019
Q4
$263K Buy
860
+196
+30% +$53.9K 0.01% 454
2019
Q3
$158K Buy
664
+4
+0.6% +$1.1K 0.01% 503
2019
Q2
$186K Buy
660
+5
+0.8% +$1.37K 0.01% 453
2019
Q1
$188K Buy
655
+61
+10% +$17.6K 0.01% 311
2018
Q4
$156K Buy
594
+81
+16% +$22.3K 0.01% 314
2018
Q3
$141K Sell
513
-1,784
-78% -$463K 0.01% 303
2018
Q2
$1.36M Buy
2,297
+1,874
+443% +$434K 0.1% 108
2018
Q1
$93K Buy
423
+52
+14% +$12.2K 0.01% 301
2017
Q4
$84K Buy
371
+52
+16% +$11.1K 0.01% 271
2017
Q3
$61K Buy
319
+26
+9% +$4.95K 0.01% 241
2017
Q2
$55K Buy
+293
New +$52.6K ﹤0.01% 249
2016
Q1
$34K Buy
+206
New +$27.5K 0.02% 246

Other funds holding ELV

ETF Managers Group's ELV Position: Q2 2021 in Review

ETF Managers Group sold out of Elevance Health (ELV) in Q2 2021, closing a stake of 1,468 shares — an estimated $534K sold.

ETF Managers Group first reported a position in ELV in Q1 2016 and held it in 17 quarters. The position peaked at $1.36M in Q2 2018. 1,238 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

  • ETF Managers Group reported no remaining Elevance Health position as of Q2 2021 after selling out during the quarter.
  • ETF Managers Group sold 1,468 Elevance Health shares in Q2 2021, an estimated $534K.
  • ETF Managers Group first reported a position in Elevance Health in Q1 2016 and held it in 17 quarters.
  • ETF Managers Group's Elevance Health position peaked at $1.36M in Q2 2018.
  • 1,238 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on ETF Managers Group's 13F filing for Q2 2021, filed 16 Aug 2021.